Team

PanTher’s skilled management team offers years of experience in oncology, biomedical devices, business, and entrepreneurship.

Laura Indolfi

Chief Executive Officer, Co-Founder

Dr. Indolfi combines the science and business knowledge to drive our vision. Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools.

She was named a TED Fellow, one of 21 people chosen annually by the TED organization who are considered to be the most disruptive and transformative change-makers in the world. In 2017, Laura attended the prestigious conference “Fortune: Most Powerful Women – Next Gen”, an invite-only summit hosted by Fortune gathering a stellar group of game-changing entrepreneurs, executives and innovators in business.

David Mackey

Chief Operating Officer

Mr. Mackey is senior finance and operations executive with a 20-year track record of building, leading, and advising businesses in all phases of the corporate life cycle. He most recently served as President and CFO of Lantos Technologies, where he led numerous strategic financings, and was responsible for business and manufacturing operations. Prior to that, he served as CFO of AgNovos Healthcare and Vice President, Investment Banking at J.P. Morgan. He began his career as a corporate attorney at Gibson, Dunn & Crutcher in New York. Mr. Mackey holds a J.D. from the University of Pennsylvania and a B.A. from Colorado State University.

David Ting

Scientific Co-Founder

Dr. Ting is a translational pancreatic cancer researcher and practicing board certified oncologist at the Massachusetts General Hospital (MGH) Cancer Center. He obtained BS degrees in both biology and chemical engineering from MIT and completed his MD at Harvard Medical School. He performed biomedical research under Dr. Robert Langer working on DNA vaccine delivery systems and then a Howard Hughes Medical Fellowship with Dr. George Daley on stem cell research.

David is now an Assistant Professor at the MGH Cancer Center and Harvard Medical School directing a translational research laboratory focused on pancreatic cancer.

J. Marc Pipas

Chief Medical Officer

Dr. Pipas is a veteran GI oncologist and clinical trialist who has assisted in development of multiple oncology agents from Phase I through commercialization. He will direct PanTher’s clinical development programs. Marc spent more than 20 years at Dartmouth Medical School and Dartmouth-Hitchcock Medical Center, where he was promoted to Full Professor and served as Director of the GI Oncology Program, and Interdisciplinary Pancreas Cancer Clinic. Following his academic career, Dr. Pipas joined Merrimack Pharmaceuticals as Vice President Medical Director. Most recently, Marc served as Executive Medical Director, Clinical Development at H3 Biomedicine.

Meg Lashof-Sullivan

Senior Scientist

Dr. Lashof-Sullivan is a biomedical engineer with a background in biomaterials. She has expertise in polymer synthesis, drug delivery, and analytical laboratory techniques.

Meg received her B.E. degree from the Thayer School of Engineering at Dartmouth College, and her PhD in Biomedical Engineering from Case Western Reserve University.

She completed postdoctoral training at the Naval Medical Research Center’s NeuroTrauma department.

Elazer Edelman

Scientific Co-Founder

Key Opinion Leader in local drug delivery and implantable devices, Dr. Edelman serves as an advisor for the FDA and several companies in the medical device industry, and has been instrumental in propelling a number of critical devices from conceptualization to clinical realization.

Elazer is a Professor of Health Sciences and Technology at MIT and Professor of Medicine at Harvard Medical School. He also directs the Harvard-MIT Biomedical Engineering Center (BMEC), dedicated to applying the rigors of the physical sciences to elucidate fundamental biologic processes and mechanisms of disease.